Gallize Pharmaceuticals LLP
About Gallize Pharmaceuticals LLP
Data last updated:
Gallize Pharmaceuticals LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 January 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAF-4255. Its GSTIN is 24AAPFG2109K1ZE (Gujarat).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Shrujalbahen Kaumilbhai Modi and Sonalben Navin Modi.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at GF – 10 Malhar Complex Mukti Park Soc. Vibhag – 4 Nr. Sola Over Bridge Ghatlodiya, Ahmedabad, Gujarat, India – 380061.
As per MCA filings, the LLP has open charges of ₹2.95 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGF – 10 Malhar Complex Mukti Park Soc. Vibhag – 4 Nr. Sola Over Bridge Ghatlodiya, Ahmedabad, Gujarat, India – 380061
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Gallize Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Gallize Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gallize Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Gallize Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Gallize Pharmaceuticals LLP
Gallize Pharmaceuticals has 4 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrujalbahen Kaumilbhai Modi Also directs: Tripada Lifecare Private Limited | Designated Partner | 04 Jan 2016 | 10 Years 9 Months | Current |
| Sonalben Navin Modi | Partner | 04 Jan 2016 | 10 Years 9 Months | Current |
| Kaumil Navnitbhai Modi Also directs: THC Pharma Wellness Private Limited, Smonkare Impex Private Limited, Tripada Healthcare Private Limited and 2 more | Designated Partner | 04 Jan 2016 | 10 Years 9 Months | Current |
| Navin Dahyalal Modi | Partner | 04 Jan 2016 | 10 Years 9 Months | Current |
Charges & Borrowings of Gallize Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2021 | Icici Bank Limited | ₹1.8 Cr | Open |
| 07 Jul 2016 | Icici Bank Limited | ₹1.15 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Gallize Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Gallize Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gallize Pharmaceuticals LLP
Gallize Pharmaceuticals LLP has 6 designated partner changes on record since 2016: 4 appointments and 2 cessations. The latest: Navin Dahyalal Modi ceased to be Designated Partner on 04 Aug 2022.
Credit Ratings, Litigation & Regulatory Alerts for Gallize Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gallize Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gallize Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gallize Pharmaceuticals LLP
Gallize Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPFG2109K1ZE | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gallize Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gallize Pharmaceuticals LLP
Gallize Pharmaceuticals is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 04 January 2016 (10+ years old) and is registered under LLPIN AAF-4255.
Gallize Pharmaceuticals has 4 current designated partners:
- Shrujalbahen Kaumilbhai Modi - Designated Partner
- Sonalben Navin Modi - Partner
- Kaumil Navnitbhai Modi - Designated Partner
- Navin Dahyalal Modi - Partner
The GSTIN of Gallize Pharmaceuticals is 24AAPFG2109K1ZE, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Gallize Pharmaceuticals is AAF-4255. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Gallize Pharmaceuticals was incorporated on 04 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Navin Dahyalal Modi ceased to be Designated Partner on 04 Aug 2022. Sonalben Navin Modi ceased to be Designated Partner on 04 Aug 2022. Kaumil Navnitbhai Modi was appointed as Designated Partner on 04 Jan 2016. Gallize Pharmaceuticals has 6 designated partner changes on record in total.
The registered office of Gallize Pharmaceuticals is at GF – 10 Malhar Complex Mukti Park Soc. Vibhag – 4 Nr. Sola Over Bridge Ghatlodiya, Ahmedabad, Gujarat, India – 380061.
The total obligation of contribution is ₹1 Lakh.
Gallize Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Gallize Pharmaceuticals has open charges of ₹2.95 Cr and no satisfied charges on record as per latest MCA filings.